MDB Capital Holdings
  • About
    • About Us
    • Team
    • Holistic Model
  • Criteria
  • Process
  • Community
  • Companies
  • Investors
  • Submit Your Big Idea
Select Page

MDB Capital Holdings Announces Closing of Public Offering of $20 Million

by Tony Dammicci | Sep 20, 2023 | Press Releases

Shares to Begin Trading on NASDAQ on September 21, 2023 Under the Ticker Symbol “MDBH” ADDISON, TX / ACCESSWIRE / September 20, 2023 / MDB Capital Holdings, LLC, (NASDAQ:MDBH) (“MDB”), a public venture platform with the objective of growing the...

Video: MDB Capital Holdings Offering Presentation (Tahoe)

by Tony Dammicci | Sep 8, 2023 | Press Releases

The presentation included herein is a free writing prospectus and is an offer to purchase Class A Common Shares of MDB Capital Holdings, LLC (the ”Company”) in a public offering of securities of the Company.  The Company has filed with the Securities and Exchange...

Video: MDB Capital Holdings Offering Presentation

by Tony Dammicci | Aug 7, 2023 | Press Releases

 The presentation included herein is a free writing prospectus and is an offer to purchase Class A Common Shares of MDB Capital Holdings, LLC (the ”Company”) in a public offering of securities of the Company.  The Company has filed with the Securities and Exchange...

Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D)

by Tony Dammicci | Mar 15, 2023 | Press Releases

Paris and  Red Bank, N.J. March  13, 2023 Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under...

MDB Capital Holdings Announces Third MDB-Launched Company to Achieve FDA Approval

by Jim Foley | Nov 29, 2022 | Press Releases

DALLAS, T.X. / ACCESSWIRE / November 29, 2022 / MDB Capital Holdings, LLC, a privately-held public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today announced that...

Public Ventures LLC Completes First Public Company Financing as a Broker-Dealer for Cue Biopharma, Inc. (Nasdaq:CUE)

by Jim Foley | Nov 17, 2022 | Press Releases

DALLAS, TX / ACCESSWIRE / November 17, 2022 / Public Ventures, LLC, a wholly owned subsidiary of MDB Capital Holdings, LLC, completed its first financing as a broker-dealer for Cue Biopharma, Inc. (NASDAQ:CUE). The Public Ventures’ portion of the financing was...
« Older Entries

Recent Posts

  • MDB Capital Holdings Announces Closing of Public Offering of $20 Million
  • Video: MDB Capital Holdings Offering Presentation (Tahoe)
  • Video: MDB Capital Holdings Offering Presentation
  • Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D)
  • MDB Capital Holdings Announces Third MDB-Launched Company to Achieve FDA Approval

Recent Comments

    Archives

    • September 2023
    • August 2023
    • March 2023
    • November 2022
    • October 2022
    • August 2022
    • July 2022
    • June 2022

    Categories

    • Press Releases
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    AboutCriteriaProcessCommunityCompaniesTeamInvestorsContact

    Governance   Terms of Use   Business Continuity
    © 2023 MDB Capital Holdings